News Article

August 16 2012

As a key step toward providing patients with more personalized treatments based on their own DNA profiles, the Department of Pathology, the University of Michigan Medical School, the UM Hospitals and Health Centers and the International Genomics Consortium (IGC) launched Paradigm, a new joint venture that will help usher in an age of personalized medicine, on August 1.  See the complete story at

Rate this Article: